Reintroduced Humane Cosmetics Act Mum On FDA’s Role
This article was originally published in The Rose Sheet
Executive Summary
While the previous session’s iteration of the Humane Cosmetics Act attracted support from nearly 40% of the House, it did not advance – a fate sponsors hope to avoid with broad bipartisan support and assurances that the bill would not hurt businesses.